Highlights
About
Measuring Oxidative Stress for IVF Applications
Carmel Diagnostics has developed a method for measuring the oxidative stress (OS) of biological liquids, a recognized biomarker of health and disease and a key diagnostics parameter. This OS parameter is measured using thermochemiluminescence (TCL) technology. The company's lead product is focused on the process of embryo selection in in-vitro fertilization (IVF). The Fertissimo TCL Analyzer is a noninvasive embryo selection system for the IVF market, offering up to a 20% increase in successful IVF pregnancies. Effective embryo viability assessment significantly improves the success rate and reduces the risk of multiple births. Carmel Diagnostics has performed two successful proof-of-concept studies covered by peer-reviewed articles on the applications of risk stratification for patients with congestive heart failure and embryo selection in the IVF process, and is currently performing a clinical validation study for the IVF application. Carmel Diagnostics was awarded a Horizon 2020 phase-2 grant.
Identity
| Name | Carmel Diagnostics |
|---|---|
| Slug | carmel-diagnostics1 |
| Former names | Lumitest |
| Type / kind | startup |
| Crunchbase ID | carmel-diagnostics |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6B0IwIDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | North District |
| HQ city | Kiryat Tiv'on |
| HQ address | Khayim Barlev St 9, Kiryat Tiv'on, Israel |
Web & social
Classifications
Funding
| Total raised | $6.9M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}